Justin Brogan

Justin Brogan is an associate in the firm’s Business Law department and a member of its Technology and Life Sciences group. Justin works with clients on a wide array of corporate matters, including venture capital and growth equity financings, mergers and acquisitions, capital markets transactions and SEC compliance. He joined Goodwin in 2022.

Justin’s recent representations, among others, include:

Capital Markets and Mergers & Acquisitions:

• Klaviyo in its $659 million initial public offering
• Klaviyo in its acquisition of Gatsby Tech
• HI-Bio in its up to sale to Biogen
• HubSpot in its acquisition of Dashworks Technologies
• Markforged Holding Corporation (NYSE: MKFG) in its sale to Nano Dimension (Nasdaq: NNDM)
• DataRobot in its acquisition of Agnostiq
• Ultimate.ai in its sale to Zendesk
• Veracode in its acquisition of Longbow Security
• Xcoding Labs in its sale to Datadog
• Verisma Systems in its acquisition of ScanSTAT Technologies
• Verisma Systems in its acquisition of Olah Healthcare Technology

Private Financings:

• General Catalyst in various investments
• FamilyWell in its Series Seed financing
• Novo Holdings in its Series E investment in Cleveland Diagnostics
• Mantra Health in its Series A-1 financing

Justin is a member of the Boston Bar Association and Massachusetts LGBTQ Bar Association.

During law school, Justin was the recipient of Goodwin’s Wayne A. Budd & Marian A. Tse Scholarship.